Share Your Research, Maximize Your Social Impacts
Use Of Sodium - Glucose Co - Transporter - 2 Inhibitors In Hospitalized Patients With Acute Heart Failure
Journal: International Journal of Diabetology & Vascular Disease Research (IJDVR) (Vol.09, No. 01)Publication Date: 2021-06-18
Authors : Nasser Mikhail;
Page : 266-269
Keywords : SGLT2 Inhibitors; Acute Heart Failure; Euglycemic Diabetic Ketoacidosis; Safety; Empagliflozin; Sotagliflozin; Dapagliflozin; Hospitalization.;
Source : Download
Find it from : Google Scholar
Abstract
Efficacy and safety of initiation of sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients hospitalized with acute heart failure are unclear
Other Latest Articles
- Foot Self-Care Positive Behaviorin Adults with Diabetes Following an Educational Intervention
- Comparison of Glycemic Control between Intensive Insulin Regimen and Continuous Subcutaneous Insulin infusion: A Meta-Analysis Report of Type-1 Diabetics from Randomized Controlled Trials
- TRACK Implementation among Bangladeshi Population
- Association between High Sensitive-C Reactive Protein and Lipid Cardiovascular Risk Factors in Apparently Healthy Nigerian Young Adults
- Total Adiponectin and Risk of Symptomatic Lower Extremity Peripheral Vascular Disease in Type 2 Diabetes Mellitus
Last modified: 2021-10-28 19:51:43